Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis

OBJECTIVES: To investigate the influence of early disease-modifying antirheumatic drug (DMARD) treatment on long-term functional outcome in patients with recent-onset inflammatory polyarthritis (IP), and the impact of the duration of first and subsequent DMARD treatment. METHODS: 642 subjects from a...

Descripción completa

Detalles Bibliográficos
Autores principales: Farragher, Tracey M, Lunt, Mark, Fu, Bo, Bunn, Diane, Symmons, Deborah P M
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2009
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927614/
https://www.ncbi.nlm.nih.gov/pubmed/19858538
http://dx.doi.org/10.1136/ard.2009.108639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927614/
https://www.ncbi.nlm.nih.gov/pubmed/19858538
http://dx.doi.org/10.1136/ard.2009.108639

Ejemplares similares